Malibu Boats, Inc. Announces Second Quarter Fiscal 2019 Results
LOUDON, Tenn., Feb. 06, 2019 (GLOBE NEWSWIRE) — Malibu Boats, Inc. (Nasdaq: MBUU) today announced its financial results for the […]
Victory Capital Reports Fourth Quarter 2018 Results
Fourth Quarter 2018 Highlights¹ Assets under management (“AUM”) of $52.8 billion Strong investment performance, with 57%, 68%, 74% and 88% […]
Axsome Therapeutics Receives FDA Agreement under Special Protocol Assessment (SPA) for the MOMENTUM Phase 3 Trial of AXS-07 in Migraine
FDA agreement achieved on Phase 3 trial design, endpoints, and statistical approach Trial to enroll patients with a history of […]
BioCryst Strengthens Cash Position With Flexible $100 Million Debt Facility
—New loan facility increases to $50 million to further extend cash runway— —Additional $30 million available at company option following […]
InflaRx Announces Presentation of New Clinical Data with Lead Candidate IFX-1 in Hidradenitis Suppurativa
Retrospective long-term results from phase IIa trial indicate sustained remission post IFX-1 treatment Baseline characteristics from ongoing phase IIb SHINE […]
IRADIMED CORPORATION Announces Fourth Quarter 2018 Financial Results
Reports fourth quarter 2018 revenue of $8.3 million Reports fourth quarter 2018 GAAP diluted EPS of $0.14 and non-GAAP diluted […]
Kamada Announces Additional Interim Results from Phase 2 Proof of Concept Clinical Trial of Intravenous Alpha-1 Antitrypsin Treatment for Prevention of Lung Transplant Rejection
Kamada’s IV-AAT demonstrated a trend towards improvements in multiple clinical outcomes, including days on mechanical ventilation post-transplant, pulmonary function at […]
Manhattan Bridge Capital, Inc. Declares Quarterly Dividend
GREAT NECK, N.Y., Feb. 06, 2019 (GLOBE NEWSWIRE) — Manhattan Bridge Capital, Inc. (NASDAQ: LOAN) announced today that its board […]
Capricor Resumes Dosing of Enrolled Patients in HOPE-2 Clinical Trial for Duchenne Muscular Dystrophy
LOS ANGELES, Feb. 06, 2019 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a clinical-stage biotechnology company, today announced that it […]
Fossil Group, Inc. to Hold Fourth Quarter and Fiscal 2018 Earnings Conference Call and Webcast on Wednesday, February 13, 2019 at 5:00pm ET
RICHARDSON, Texas, Feb. 06, 2019 (GLOBE NEWSWIRE) — Fossil Group, Inc. (NASDAQ: FOSL) announced today that its earnings for the […]
